Skip to main content

Advertisement

Log in

Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate

  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

There is intense interest in the identification of novel biomarkers which improve the diagnosis of heart failure. Serum samples from 52 patients with systolic heart failure (EF < 40% plus signs and symptoms of failure) and 57 controls were analyzed by gas chromatography – time of flight – mass spectrometry and the raw data reduced to 272 statistically robust metabolite peaks. 38 peaks showed a significant difference between case and control (p < 5 × 10−5). Two such metabolites were pseudouridine, a modified nucleotide present in t- and rRNA and a marker of cell turnover, as well as the tricarboxylic acid cycle intermediate 2-oxoglutarate. Furthermore, 3 further new compounds were also excellent discriminators between patients and controls: 2-hydroxy, 2-methylpropanoic acid, erythritol and 2,4,6-trihydroxypyrimidine. Although renal disease may be associated with heart failure, and metabolites associated with renal disease and other markers were also elevated (e.g. urea, creatinine and uric acid), there was no correlation within the patient group between these metabolites and our heart failure biomarkers, indicating that these were indeed biomarkers of heart failure and not renal disease per se. These findings demonstrate the power of data-driven metabolomics approaches to identify such markers of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Amuro, Y., Nakaoka, H., Shimomura, S., Fujikura, M., Yamamoto, T., Tamura, S., Hada, T., Higashino, K. (1988) Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. Clin. Chim. Acta, 178, 151–158

    Article  PubMed  CAS  Google Scholar 

  • Anker, S.D., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C.H., Cicoira, M., Shamim, W., Kemp, M., Segal, R., Osterziel, K.J., Leyva, F., Hetzer, R., Ponikowski, P., Coats, A.J. (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation, 107, 1991–1997

    Article  PubMed  Google Scholar 

  • Bland, J.M., Altman, D.G. (1995) Multiple significance tests: the Bonferroni method. BMJ, 310, 170

    PubMed  CAS  Google Scholar 

  • Bongartz, L.G., Cramer, M.J., Doevendans, P.A., Joles, J.A., Braam, B. (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur. Heart. J., 26, 11–7

    Article  PubMed  Google Scholar 

  • Broadhurst, D., Kell, D.B. (2006) Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171–196; DOI: 10.1007/s11306-006-0037-z

    Article  CAS  Google Scholar 

  • Bultitude, F.W., Newham, S.J. (1975) Identification of some abnormal metabolites in plasma from uremic subjects. Clin. Chem., 21, 1329–1334

    PubMed  CAS  Google Scholar 

  • Charette, M., Gray, M.W. (2000) Pseudouridine in RNA: what, where, how, and why. IUBMB Life, 49, 341–351

    Article  PubMed  CAS  Google Scholar 

  • Csete, M., Doyle, J. (2004) Bow ties, metabolism and disease. Trends Biotechnol., 22, 446–450

    Article  PubMed  CAS  Google Scholar 

  • Culleton, B.F., Larson, M.G., Evans, J.C., Wilson, P.W., Barrett, B.J., Parfrey, P.S., Levy, D. (1999a) Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch. Intern. Med. 159, 1785–1790

    Article  PubMed  CAS  Google Scholar 

  • Culleton, B.F., Larson, M.G., Kannel, W.B., Levy, D. (1999b) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann. Intern. Med., 131, 7–13

    PubMed  CAS  Google Scholar 

  • De Sousa, E., Veksler, V., Bigard, X., Mateo, P., Ventura-Clapier, R. (2000) Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102, 1847–1853

    PubMed  Google Scholar 

  • DiCiccio, T.J., Efron, B. (1996) Bootstrap confidence intervals. Stat. Sci., 11, 189–228

    Article  Google Scholar 

  • Drexler, H., Riede, U., Munzel, T., Konig, H., Funke, E., Just, H. (1992) Alterations of skeletal muscle in chronic heart failure. Circulation, 85, 1751–1759

    PubMed  CAS  Google Scholar 

  • Duarte, N.C., Becker, S.A., Jamshidi, N., Thiele, I., Mo, M.L., Vo, T.D., Srvivas, R., Palsson, B.Ø. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. 104, 1777–1782

    Article  PubMed  CAS  Google Scholar 

  • Dunn, W.B., Ellis, D.I. (2005) Metabolomics: current analytical platforms and methodologies. Trends Anal. Chem. 24, 285–294

    Article  CAS  Google Scholar 

  • Efron, B., Gong, G. (1983) A leisurely look at the bootstrap, the jackknife, and cross-validation. American Statistician 37, 36–48

    Article  Google Scholar 

  • Efron, B., Tibshirani, R.J. (1993) Introduction to the Bootstrap. London, Chapman and Hall

    Google Scholar 

  • Finck, B.N., Kelly, D.P. (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615–622

    Article  PubMed  CAS  Google Scholar 

  • Harrigan G.G., Goodacre R. (Eds) (2003) Metabolic Profiling: its Role in Biomarker Discovery and Gene Function analysis. Boston, Kluwer Academic Publishers

    Google Scholar 

  • Hierro, E., Ordonez, J., Bruna, J. M., Pin, C., Fernandez, M., de la Hoz, L. (2005) Volatile compound generation in dry fermented sausages by the surface inoculation of selected mould species. Eur. Food Res. Technol. 220, 494–501

    Article  CAS  Google Scholar 

  • Higley, B., De Mello, J., Jr., Oakes, D.J., Giles, G. R. (1982) Serum pseudouridine concentration as a marker of gastrointestinal cancer. Clin. Oncol. 8, 305–312

    PubMed  CAS  Google Scholar 

  • Hollander, M., Wolfe, D.A. (1973) Nonparametric Statistical Methods. New York, Wiley

    Google Scholar 

  • Jauniaux, E., Hempstock, J., Teng, C., Battaglia, F. C., Burton, G.J. (2005) Polyol concentrations in the fluid compartments of the human conceptus during the first trimester of pregnancy: maintenance of redox potential in a low oxygen environment. J. Clin. Endocrinol. Metab. 90, 1171–1175

    Article  PubMed  CAS  Google Scholar 

  • Kell, D.B. (2004) Metabolomics and systems biology: making sense of the soup. Curr. Op. Microbiol. 7, 296–307

    Article  CAS  Google Scholar 

  • Kell, D.B. (2006a) Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor Bücher lecture FEBS J. 273, 873–894

    Article  PubMed  CAS  Google Scholar 

  • Kell, D.B. (2006b) Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Disc. Today, 11, 1085–1092

    Article  CAS  Google Scholar 

  • Kell, D.B., Oliver, S.G. (2004) Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays 26, 99–105

    Article  PubMed  Google Scholar 

  • Kenny, L.C., Dunn, W.B., Ellis, D.I., Myers, J., Baker, P. N., The GOPEC Consortium and Kell, D.B. (2005) Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning. Metabolomics. 1, 227–234 - online DOI: 10.1007/s11306–005-0003-1

  • Kirschenlohr, H.L., Griffin, J.L., Clarke, S.C., Rhydwen, R., Grace, A.A., Schofield, P.M., Brindle, K. M., Metcalfe, J. C. (2006) Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat. Med., 12, 705–710

    Article  PubMed  CAS  Google Scholar 

  • Leyva, F., Anker, S., Swan, J.W., Godsland, I.F., Wingrove, C.S., Chua, T.P., Stevenson, J.C., Coats, A.J. (1997) Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur. Heart. J. 18, 858–865

    PubMed  CAS  Google Scholar 

  • Leyva, F., Anker, S.D., Godsland, I.F., Teixeira, M., Hellewell, P.G., Kox, W.J., Poole-Wilson, P.A., Coats, A.J. (1998a) Uric acid in chronic heart failure: a marker of chronic inflammation. Eur. Heart. J. 19, 1814–1822

    Article  PubMed  CAS  Google Scholar 

  • Leyva, F., Chua, T.P., Anker, S.D., Coats, A.J. (1998b) Uric acid in chronic heart failure: a measure of the anaerobic threshold. Metabolism 47, 1156–1159

    Article  PubMed  CAS  Google Scholar 

  • Mackay, D.J.C. (2003) Information Theory, Inference and Learning Algorithms. Cambridge: Cambridge University Press

    Google Scholar 

  • Morgan, H.E., Gordon, E.E., Kira, Y., Chua, H.L., Russo, L.A., Peterson, C.J., McDermott, P.J., Watson, P. A. (1987) Biochemical mechanisms of cardiac hypertrophy. Annu. Rev. Physiol. 49, 533–543

    Article  PubMed  CAS  Google Scholar 

  • Neijssel, O.M., Tempest, D.W. (1976) The role of energy-splitting reactions in the growth of Klebsiella aerogenes NCTC 418 in aerobic chemostat culture. Arch. Microbiol. 110, 305–311

    Article  PubMed  CAS  Google Scholar 

  • Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., Pabst, T., Ertl, G., Hahn, D., Ingwall, J. S., Kochsiek, K. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation, 96, 2190–2196

    PubMed  CAS  Google Scholar 

  • Nicholson, J.K., Holmes, E., Wilson, I.D. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431–438

    Article  PubMed  CAS  Google Scholar 

  • Niwa, T., Takeda, N., Yoshizumi, H. (1998) RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note Kidney Int. 53, 1801–1806

    Article  PubMed  CAS  Google Scholar 

  • O’Hagan, S., Dunn, W.B., Broadhurst, D., Williams, R., Ashworth, J.A., Cameron, M., Knowles, J., Kell, D. B. (2007) Closed-loop, multi-objective optimisation of two-dimensional gas chromatography (GCxGC-tof-MS) for serum metabolomics. Anal. Chem. 79, 464–476

    Article  PubMed  CAS  Google Scholar 

  • O’Hagan, S., Dunn, W.B., Brown, M., Knowles, J.D., Kell, D.B. (2005) Closed-loop, multiobjective optimisation of analytical instrumentation: gas-chromatography-time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. Anal. Chem. 77, 290–303

    Article  PubMed  CAS  Google Scholar 

  • Ofengand, J. (2002) Ribosomal RNA pseudouridines and pseudouridine synthases. FEBS Lett. 514, 17–25

    Article  PubMed  CAS  Google Scholar 

  • Oliver, S.G., Winson, M.K., Kell, D.B., Baganz, F. (1998) Systematic functional analysis of the yeast genome. Trends Biotechnol. 16, 373–378

    Article  PubMed  CAS  Google Scholar 

  • Orešič, M., Vidal-Puig, A., Hänninen, V. (2006) Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev. Mol. Diagn. 6, 575–585

    Article  PubMed  Google Scholar 

  • Pan, J.P., Liu, T.Y., Chiang, S.C., Lin, Y.K., Chou, C.Y., Chan, W.L., Lai, S.T. (2004) The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure. J. Chin. Med. Assoc. 67, 222–228

    PubMed  Google Scholar 

  • Pane, F., Savoia, M., Fortunato, G., Camera, A., Rotoli, B., Salvatore, F., Sacchetti, L. (1993) Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia. Clin. Biochem., 26, 513–520

    Article  PubMed  CAS  Google Scholar 

  • Pearl, J. (2000) Causality: Models, Reasoning and Inference. Cambridge, Cambridge University Press

    Google Scholar 

  • Perneger, T.V. (1998) What’s Wrong with Bonferroni Adjustments. Bmj, 316, 1236–1238

    PubMed  CAS  Google Scholar 

  • Pitkänen, E. (1972) Serum polyol pattern and urinary polyol excretion in diabetic and in uremic patients. Clin. Chim. Acta. 38, 221–230

    Article  PubMed  Google Scholar 

  • Raamsdonk, L.M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M., Berden, J.A., Brindle, K.M., Kell, D.B., Rowland, J.J., Westerhoff, H.V., van Dam, K., Oliver, S.G. (2001) A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnol. 19, 45–50

    Article  CAS  Google Scholar 

  • Ransohoff, D.F. (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 5, 142–149

    Article  PubMed  CAS  Google Scholar 

  • Roboz, J., Kappatos, D., Holland, J.F. (1990) Polyol concentrations in serum during hemodialysis. Clin. Chem. 36, 2082–2086

    PubMed  CAS  Google Scholar 

  • Roboz, J., Kappatos, D.C., Greaves, J., Holland, J. F. (1984) Determination of polyols in serum by selected ion monitoring. Clin. Chem. 30, 1611–1615

    PubMed  CAS  Google Scholar 

  • Rothman, K.J., Greenland, S. (1998) Modern Epidemiology, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins

    Google Scholar 

  • Russo, T., Colonna, A., Salvatore, F., Cimino, F., Bridges, S., Gurgo, C. (1984) Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma. Cancer Res. 44, 2567–2570

    PubMed  CAS  Google Scholar 

  • Sabatine, M.S., Liu, E., Morrow, D.A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G.F., Roth, F.P., Gerszten, R.E. (2005) Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112, 3868–3875

    Article  PubMed  CAS  Google Scholar 

  • Sakai, H., Tsutamoto, T., Tsutsui, T., Tanaka, T., Ishikawa, C., Horie, M. (2006) Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ. J., 70, 1006–1011

    Article  PubMed  Google Scholar 

  • Salvatore, F., Russo, T., Colonna, A., Cimino, L., Mazzacca, G., Cimino, F. (1983) Pseudouridine determination in blood serum as tumor marker. Cancer Detect. Prev. 6, 531–536

    PubMed  CAS  Google Scholar 

  • Schoots, A.C., Mikkers, F.E.P., Cramers, C.A.M.G., Ringoir, S. (1979) Profiling of uremic serum by high-resolution gas chromatography-electron-impact, chemical ionization mass spectrometry. J. Chromatogr. 164, 1–8

    Article  PubMed  CAS  Google Scholar 

  • Smith, G.L., Shlipak, M.G., Havranek, E.P., Foody, J.M., Masoudi, F.A., Rathore, S.S., Krumholz, H.M. (2006) Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch. Intern. Med. 166, 1134–1142

    Article  PubMed  CAS  Google Scholar 

  • Tamura, S., Fujioka, H., Nakano, T., Hada, T., Higashino, K. (1987) Serum pseudouridine as a biochemical marker in small cell lung cancer. Cancer. Res. 47, 6138–6141

    PubMed  CAS  Google Scholar 

  • Troughton, R.W., Frampton, C.M., Yandle, T.G., Espiner, E.A., Nicholls, M.G., Richards, A.M. (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet, 355, 1126–1130

    Article  PubMed  CAS  Google Scholar 

  • Tsutamoto, T., Wada, A., Sakai, H., Ishikawa, C., Tanaka, T., Hayashi, M., Fujii, M., Yamamoto, T., Dohke, T., Ohnishi, M., Takashima, H., Kinoshita, M., Horie, M. (2006) Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J. Am. Coll. Cardiol. 47, 582–586

    Article  PubMed  CAS  Google Scholar 

  • Underwood, B.R., Broadhurst, D., Dunn, W.B., Ellis, D.I., Michell, A.W., Vacher, C., Mosedale, D.B., Kell, D.B., Barker, R., Grainger, D.J., Rubinsztein, D. C. (2006) Huntington’s disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain, 29, 877–886

    Article  Google Scholar 

  • van der Greef, J., Hankemeier, T., McBurney, R.N. (2006) Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? Pharmacogenomics, 7, 1087–1094

    Article  PubMed  Google Scholar 

  • van der Greef, J., Stroobant, P., van der Heijden, R. (2004) The role of analytical sciences in medical systems biology. Curr. Opin. Chem. Biol., 8, 559–565

    Article  PubMed  CAS  Google Scholar 

  • Verhoeven, N.M., Huck, J.H., Roos, B., Struys, E. A., Salomons, G.S., Douwes, A.C., van der Knaap, M. S., Jakobs, C. (2001) Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am. J. Hum. Genet. 68, 1086–1092

    Article  PubMed  CAS  Google Scholar 

  • Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L., Rothman, N. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer. Inst. 96, 434–442

    Article  PubMed  Google Scholar 

  • Wamelink, M.M., Smith, D.E., Jakobs, C., Verhoeven, N.M. (2005) Analysis of polyols in urine by liquid chromatography-tandem mass spectrometry: A useful tool for recognition of inborn errors affecting polyol metabolism. J. Inherit. Metab. Dis. 28, 951–963

    Article  PubMed  CAS  Google Scholar 

  • Xu, G., Schmid, H.R., Lu, X., Liebich, H.M., & Lu, P. (2000) Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Biomed Chromatogr, 14, 459–63

    Article  PubMed  CAS  Google Scholar 

  • Zaphiriou, A., Robb, S., Murray-Thomas, T., Mendez, G., Fox, K., McDonagh, T., Hardman, S.M., Dargie, H.J., Cowie, M.R. (2005) The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur. J. Heart Fail. 7, 537–541

    Article  PubMed  CAS  Google Scholar 

  • Zheng, Y.F., Kong, H.W., Xiong, J.H., Lv, S., Xu, G.W. (2005) Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Clin Biochem, 8, 24–30

    Article  CAS  Google Scholar 

Download references

Acknowledgments

DBK thanks the BBSRC, EPSRC, RSC and BHF and LN thanks the MRC and the BHF for financial support. We thank the referees for some very thoughtful and helpful comments. DBK thanks Prof Phil Baker for a useful discussion. This is a contribution from the Manchester Centre for Integrative Systems Biology (www.mcisb.org).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Douglas B. Kell or Ludwig Neyses.

Additional information

Warwick B. Dunn, David I. Broadhurst and Sasalu M. Deepak contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunn, W.B., Broadhurst, D.I., Deepak, S.M. et al. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics 3, 413–426 (2007). https://doi.org/10.1007/s11306-007-0063-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11306-007-0063-5

Keywords

Navigation